Skip to content
The Nexus
DossierENTITY

orlistat

Coverage of orlistat in the Nexus archive.

Earliest in view: Jun 10 · 20:57 UTCMost recent: Jun 10 · 20:57 UTC
Co-mentioned in this coverage
FDAorganization1allitopic1kidney stonestopic1kidney injurytopic1
Recent coverage
  • HEALTHJun 10 · 20:57 UTCMEDPAGE TODAY
    FDA Issues Safety Alert on Weight-Loss Drug's Kidney Risks

    The FDA issued a safety alert regarding the over-the-counter weight-loss drug orlistat (alli), warning of potential kidney stone and kidney injury risks. The agency approved a label change to include these warnings.